Psoriasis is not a risk factor for nonischemic dilated cardiomyopathy, according to a recent study published in BMC Cardiovascular Disorders.
Researchers aimed to examine the relationship between psoriasis and nonischemic dilated cardiomyopathy in a large population-based study. The authors investigated hospitalizations for patients aged 18 years and older with a diagnosis of any type of psoriasis and non-ischemic dilated cardiomyopathy using the Healthcare Cost and Utilization Project National Inpatient Sample 2017 database.
After examining a total of 6,084,184 all-cause admissions, the authors determined no association between psoriasis and nonischemic dilated cardiomyopathy.
“We found that [nonischemic cardiomyopathy] was more prevalent in patients with psoriasis; however, this association is likely due to higher prevalence of risk factors of [nonischemic cardiomyopathy], rather than psoriasis,” concluded the study authors. –Lisa Kuhns
Reference
Alshami A, Alfraji N, Douedi S, et al. Psoriasis as risk factor for non-ischemic dilated cardiomyopathy: a population-based cross-sectional study. BMC Cardiovasc Disord. 2021;21(1):161. doi:10.1186/s12872-021-01972-0
